NIIMBL poises Delaware as nationwide biopharma pioneer

In December 2016, Manufacturing USA, a newly developed unit within the Commerce Department’s National Institute for Standards and Technology (NIST), announced it had received Congressional funding for its newest and 11th institute – the National Institute for Innovation in Manufacturing Biopharmaceuticals, or NIIMBL for short. With the formal NIST announcement on March 1, 2017, came

Already a subscriber? Log in

To continue reading this article ...

Subscribe to Delaware Business Times right now and get access to subscriber-only content like this article.

- Advertisement -

Plus get 24 issues of DBT via print or digital, special bonus issues, and discounted registration for our in-person events.

– Digital Partners -

Important information for subscribers accessing "Insider" content

Close the CTA